CTC Clinical Trial Consultants AB

Clinical trials are central to the development of new treatments, but the process, responsibilities and participant perspective are not always visible outside the research setting. On 15 October, CTC invites you to a free webinar where Helen Fagraeus, Study Start-up and Erik Rein-Hedin, Physician will share insights into how clinical trials are conducted, why they are essential to the development of new treatments, and what participation involves from a participant’s perspective. The webinar will be held in Swedish and is open to anyone interested in learning more about clinical research. 15 October, 18:00 Online and free to attend Register here: https://lnkd.in/d3X5a4dq

CTC combines full-service CRO capabilities with an in-house Site Network across Sweden and the Netherlands. Recruitment, site operations, monitoring, data and safety are coordinated within one organisation — giving sponsors clearer oversight and fewer operational handovers.

Early development decisions depend on more than a successful first dose. CTC combines study design, clinical pharmacology, hospital-based clinical conduct, biometrics and reporting within one delivery model — helping sponsors move from protocol to interpretable data with fewer operational handovers.

Recruitment risk is rarely solved by site selection alone. CTC combines professional research units, central recruitment capabilities, patient databases and medical expertise to support enrolment and keep site delivery aligned with the study plan.

Our network of state-of-the-art clinics, including two First-in-Human (FIH) units, offers both in- and out-patient capacity to meet diverse trial needs - End-to-end CRO services across our clinics - In- and out-patient capabilities, - Network of medical experts and KOL’s, - Efficient recruitment & excellent trial execution

Pfizer and Valneva report strong Phase 3 results for a Lyme disease vaccine candidate — an important step forward in addressing a growing infectious disease challenge. CTC contributed substantially as a clinical trial site in this large, global study, with participation from our in-house sites, CTC Stockholm and CTC MTC, Uppsala. The study at CTC was led by Principal Investigators Erik Rein-Hedin and Dr Jian F. Being part of a study of this scale highlights the role of experienced clinical sites in supporting global development programs. Read more: https://lnkd.in/g7qCu3dk